| High-affinity peptidomimetic inhibitors of the DCN1-UBC12 protein–protein interaction H Zhou, W Zhou, B Zhou, L Liu, TR Chern, K Chinnaswamy, J Lu, ... Journal of Medicinal Chemistry 61 (5), 1934-1950, 2018 | 54 | 2018 |
| Cyclopeptide Smac mimetics as antagonists of IAP proteins H Sun, L Liu, J Lu, S Qiu, CY Yang, H Yi, S Wang Bioorganic & medicinal chemistry letters 20 (10), 3043-3046, 2010 | 52 | 2010 |
| Adaptive nonparametric CUSUM scheme for detecting unknown shifts in location L Liu, F Tsung, J Zhang International Journal of Production Research 52 (6), 1592-1606, 2014 | 51 | 2014 |
| Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeutics S Wang, L Bai, J Lu, L Liu, CY Yang, H Sun Journal of mammary gland biology and neoplasia 17, 217-228, 2012 | 48 | 2012 |
| A sequential rank-based nonparametric adaptive EWMA control chart L Liu, X Zi, J Zhang, Z Wang Communications in Statistics-Simulation and Computation 42 (4), 841-859, 2013 | 44 | 2013 |
| Targeting Mll1 H3K4 methyltransferase activity to guide cardiac lineage specific reprogramming of fibroblasts L Liu, I Lei, H Karatas, Y Li, L Wang, L Gnatovskiy, Y Dou, S Wang, L Qian, ... Cell Discovery 2 (1), 1-11, 2016 | 42 | 2016 |
| Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell … H Sun, J Lu, L Liu, CY Yang, S Wang ACS chemical biology 9 (4), 994-1002, 2014 | 42 | 2014 |
| Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same S Wang, H Zhou, J Chen, A Aguilar, JL Meagher, D Sun, CY Yang, L Liu, ... US Patent 8,691,184, 2014 | 42 | 2014 |
| Adaptive phase II nonparametric EWMA control chart with variable sampling interval L Liu, B Chen, J Zhang, X Zi Quality and Reliability Engineering International 31 (1), 15-26, 2015 | 40 | 2015 |
| Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents Y Peng, H Sun, J Lu, L Liu, Q Cai, R Shen, CY Yang, H Yi, S Wang Journal of medicinal chemistry 55 (1), 106-114, 2012 | 40 | 2012 |
| Transplantation of Isl1+ cardiac progenitor cells in small intestinal submucosa improves infarcted heart function L Wang, EM Meier, S Tian, I Lei, L Liu, S Xian, MT Lam, Z Wang Stem Cell Research & Therapy 8, 1-10, 2017 | 39 | 2017 |
| Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally … Y Zhao, L Bai, L Liu, D McEachern, JA Stuckey, JL Meagher, CY Yang, ... Journal of medicinal chemistry 60 (9), 3887-3901, 2017 | 38 | 2017 |
| A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice R Sheng, H Sun, L Liu, J Lu, D McEachern, G Wang, J Wen, P Min, Z Du, ... Journal of medicinal chemistry 56 (10), 3969-3979, 2013 | 38 | 2013 |
| Online profile monitoring for surgical outcomes using a weighted score test L Liu, X Lai, J Zhang, F Tsung Journal of Quality Technology 50 (1), 88-97, 2018 | 37 | 2018 |
| Multivariate nonparametric control chart with variable sampling interval J Yue, L Liu Applied Mathematical Modelling 52, 603-612, 2017 | 34 | 2017 |
| Structure-based discovery of CF53 as a potent and orally bioavailable bromodomain and extra-terminal (BET) bromodomain inhibitor Y Zhao, B Zhou, L Bai, L Liu, CY Yang, JL Meagher, JA Stuckey, ... Journal of medicinal chemistry 61 (14), 6110-6120, 2018 | 32 | 2018 |
| Transplantation of multipotent Isl1+ cardiac progenitor cells preserves infarcted heart function in mice Y Li, S Tian, I Lei, L Liu, P Ma, Z Wang American journal of translational research 9 (3), 1530, 2017 | 32 | 2017 |
| Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation I Lei, S Tian, W Gao, L Liu, Y Guo, P Tang, E Chen, Z Wang Elife 10, e60311, 2021 | 30 | 2021 |
| BCL-2/BCL-XL inhibitors and therapeutic methods using the same S Wang, J Chen, D McEachern, L Bai, L Liu, D Sun, X Li, A Aguilar US Patent 9,096,625, 2015 | 27 | 2015 |
| Structure-based discovery of M-89 as a highly potent inhibitor of the menin-mixed lineage leukemia (Menin-MLL) protein–protein interaction A Aguilar, K Zheng, T Xu, S Xu, L Huang, E Fernandez-Salas, L Liu, ... Journal of medicinal chemistry 62 (13), 6015-6034, 2019 | 24 | 2019 |
